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Carcinomaofprostateisthesecondmostcommon
cause of cancer death in men in the UK. It is
known that patients with carcinoma of prostate
are at significant risk of developing a second
primary neoplasm.' These second primary are
mainly colorectal, stomach or urinary bladder.
Thehistopathology ofgastrointestinal tumours is
usually adenocarcinoma. We report a case of
prostate cancer that developed an unusual
combination of atrial myxoma, small bowel
carcinoid, basal cell cancer on shoulder skin,
rectosigmoid adenocarcinoma and caecal
adenoma over a period of five years.
CASE REPORT A 73 years old man presented
withsignificantbladderoutletobstructionin 1996.
Onclinicalexaminationhehadasmoothenlarged
prostate. The postate specific antigen (PSA) was
elevated at 38.5ng/1. Transurethral resection of
prostate was performed; 21gm of this was
resected. The histopathology report was
adenocarcinoma ofprostate (Gleason score 3, in
90% ofresectedtissue). Thestaging CT scan was
normal, andbone scanrevealed a suspicious area
of increased uptake near the right femoral
metaphysis. Thepatient was started onhormonal
treatmentintheformofGoserelininjections. The
serumPSAlevelreturned tonormalwithin 1 year
and has remained within the normal range for 5
years. Abone scanrepeatedafter3 years was also
normal.
InMarch2001 thepatientpresentedwithvomiting
andabdominaldistension. X-ray showedfeatures
consistent with small bowel obstruction. An
exploratory laprotomy was carried out. A small
bowel tumour was identified with extensive
mesenteric lymphadenopathy and was resected.
Histopathologyconfirmedsmallbowelcarcinoid.
All the mesenteric lymph nodes were negative
for metastases.
In July 2001 the patient presented with bleeding
perrectum. Colonoscopy showed arectosigmoid
pedunculated polyp more than 2 centimetres and
moderatedivericulardiseaseofthesigmoidcolon.
The rectosigmoid polyp was snared and excised
andwas confirmedtobe anadenomawith afocus
of adenocarcinoma.
In 2001 a 1cm lesion on the left shoulder was
biopsied and found to be a basal cell cancer. It
was treated with flurouracil cream and colistin
sulphate and polymyxin B sulphate cream.
On routine follow-up colonoscopy in November
2001, aflatgrowthintherectumwas foundalong
with a large polypoid lesion in the caccum and a
small polyp in the transverse colon. The
histopathologyconfirmedthepresenceofarectal
adenocarcinoma and a tubulovillous adenoma of
the caecurn with no dysplasia.
InJune2000thepatientunderwent anemergency
left brachial embolectomy. Histology showed
onlybloodclot. Subsequent2Dechocardiography
confirmed the presence of a lesion with features
of atrial myxoma almost filling the entire right
atrium. After discussion with the patient,
conservative treatment of the myxoma was
decided upon and anticoagulation therapy was
started.
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The patient was also on medications for
hypertension and gout.
DISCUSSION
This patient developed multiple primary
neoplasmsofprostate, smallbowel,heart,rectum,
caecum and skin. The pathology was as varied as
adenocarcinoma, myxoma, basal cell carcinoma
and carcinoid.
Thepatientgave no familyhistory ofany disease
or malignancy. His only risk factor was heavy
smoking, which he had stopped 5-6 years before
his first diagnosis. Apart from the lesion seen on
bonescan(whichwasnotapparentonsubsequent
bone scan) there was no other evidence of
metastasis from any of the primary neoplasia.
The clinical picture in this case does not fit into
any described multisystem genetic syndromes
likeCarney orGorlin syndrome where morethan
one malignant tumour occurs.
The interval between the first two primary
neoplasms detected was 4 years. The subsequent
intervals were 2 years, 6 months, and 3 months.
This is keeping with other reported cases. For
reasons unknown, the mean interval between
diagnosis offirst two primaries is always greater
than the subsequent neoplasms detected.2
Multipleprimaryneoplasmsinasingleindividual
is a known clinical entity. It is not yet fully
understood but it is blamed on chromosomal
instability, genetic predisposition, and
environmental risk factors.
1lq13 is a homogenously mutated gene in the
majority of MEN 1 tumours, whereas BRCA1
and BRCA2 mutations might be associated with
increasedsusceptibilityfordevelopingmorethan
one neoplasm in cancer of breast or ovary. This
suggests that a single mutation can bring about
malignant change in more than one organ.9 10
A patient with heritable cancer syndromes often
develops multiple primary cancer (MPCs)
suggesting hereditary predisposition.
Out of50,000 cancer cases recorded at National
Cancer Center Japan, 2000 had MPCs. This
frequency is rising in Japan probably due to
exposure to carcinogens.3 Thus environmental
factors, carcinogens, genetic predisposition,
mutations, and even heredity and familial
syndromesarethoughttoplayaroleindeveloping
MPCs.
It has been noted that patients with carcinoma of
prostate are at a significant risk of developing
secondmalignancy(ashighas 15.2%inaJapanese
study).2'5 Stomach, urinary bladder, colon and
lungs are the commonly involved organs.8 It has
also been reported (as seen in this case report)
that overall survival of patients with prostate
cancer was not significantly reduced by the
associationofMPCs,2,4andchancesofdeveloping
MPCs increase with the tumour grade,5 and the
factthatapatientalreadyhasamalignancymakes
him prone for MPCs.6
CONCLUSION
Patients with cancer prostate are at high risk of
developing multiple primary neoplasms. The
mechanism howeveris notfully understood. The
mean interval between detection of second
primary neoplasm after carcinoma ofprostate is
usually longer than subsequent detection of
neoplasms. Multiple primary cancers however
do not seem to significantly affect the overall
survival ofpatients with prostate cancer.
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